Challenging Diagnostic and Management Questions in Syphilis: A Case-Based Approach
Overview Assessment of Needs The rates of syphilis continue to increase in both men and women. Using a case-based approach, the goal of this webinar is to provide practical information for clinicians who manage patients with syphilis, including a description of the less common clinical manifestations, challenging management questions, and future interventions that could (more…)
HIV, COVID-19, and Sexually Transmitted Infections: Update and Implications for Practice
Due to the rapid rise of COVID-19 delta variant infections, we have come to the difficult decision that it is unsafe and impractical to have the hybrid component of the HIV, COVID-19, and Sexually Transmitted Infections: Update and Implications for Practice. The course is now fully virtual. Our first and foremost concern (more…)
Update on Tuberculosis/HIV Coinfection: Across the Spectrum From Latent Infection Through Drug-Susceptible and Drug-Resistant Disease
Overview Assessment of Needs This webinar will review the landscape of tuberculosis (TB) and HIV coinfection across the disease spectrum, from latent infection to drug-susceptible and drug-resistant disease. Recent advances include TB preventive therapy for 1 month, which is safe and effective, and a 4-month regimen, after 40 years of a 6-month treatment for (more…)
PrEParing for PrEP: From Policy to Implementation
This course was initially planned as a hybrid activity, with a virtual component, and with a possible in-person component at the National Press Club in Washington, DC. We have decided that it is unsafe and impractical to have the in-person component of the PrEParing for PrEP: From Policy to Implementation. The course is now (more…)
The Latest on the Omicron Variant, Therapeutics, and COVID-19 in People Who Are Immunocompromised
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will be a continued discussion of the October 22nd Dialogue regarding an update on COVID-19 in (more…)
The SARS-CoV-2 Pandemic: Where Are We Now?
Overview Assessment of Needs Dr George W. Rutherford, a leading epidemiologist who has played a significant role in the COVID-19 response, will provide the latest information on the Omicron variant and the current epidemiology of SARS-CoV-2 infection in the United States. This webinar will discuss various control strategies, particularly in vaccination, and how they (more…)
How Will COVID-19 Vaccine Development Influence Future HIV Vaccine Efforts?
Overview Assessment of Needs Despite 4 decades of efforts and substantial progress in preventing, treating, and managing HIV/AIDS, a safe and effective HIV vaccine continues to be elusive. The development of an HIV vaccine would have a major impact on the spread of this disease and help change the course of the HIV pandemic. (more…)
Latest Update on COVID-19 Vaccines and Scientific Leaders’ Perspectives on When Can We Be “Normal” and Are We at a Pandemic Inflection Point?
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. This Dialogue will provide a discussion on the latest issues regarding COVID-19 vaccines, particularly the immunization of children, (more…)
Weight Gain: A Growing Issue in Antiretroviral Therapy
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians. Weight gain is common among people with HIV (PWH) who are starting antiretroviral therapy (ART), with regimens containing integrase strand transfer inhibitors (InSTIs) or (more…)
CROI 2022 Update: Highlights in Clinical Research With a Focus on Antivirals
Overview Assessment of Needs This webinar will highlight important new clinical data presented at the recent 2022 Conference on Retroviruses and Opportunistic Infections from February 12 to 16, with symposia from February 23, 24, and 25. Learning Objectives At the end of this webinar, participants will be able to: List the most recent findings from (more…)